IGF1R and hepatocellular carcinoma: Inhibiting the menin–MLL interaction with MI-3 repressed the growth of HCC cell lines that highly express IGF2 by reducing H3K4me3 at the IGF2 promoter, decreasing IGF2 expression, and subsequently inhibiting IGF1R-Akt pathway activation [220].